The ARBE chip project has been really tough recently, dropping 90% from SPAC financing to now. It's understandable that many people are pessimistic. The technical risks during the experimental phase and the dilution pressure from financing are all real issues. But recently, this step is very critical—the chip business has just achieved significant progress. This is a high-growth track, and technological breakthroughs could lead to a revaluation. The market may not have fully reacted yet.